A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses

Journal Article A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses Get access David R Raleigh, David R Raleigh Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, California, USA Corresponding Author: David R. Raleigh, MD, PhD, Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, Helen Diller Family Cancer Research Building, 1450 3rd Street, HD481, San Francisco, CA 94158, USA (david.raleigh@ucsf.edu) https://orcid.org/0000-0001-9299-8864 Search for other works by this author on: Oxford Academic PubMed Google Scholar Matthias Preusser Matthias Preusser Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria (M.P.) https://orcid.org/0000-0003-3541-2315 Search for other works by this author on: Oxford Academic PubMed Google Scholar Neuro-Oncology, Volume 26, Issue 2, February 2024, Pages 207–208, https://doi.org/10.1093/neuonc/noad212 Published: 15 November 2023 Article history Corrected and typeset: 15 November 2023 Published: 15 November 2023